Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Oral Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous in Chronic Kidney Disease

NCT04311645 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04311645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04311645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Oral Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous in Chronic Kidney Disease
Lead sponsor
Assiut University
Phase
Phase 2
Overall status
Unknown status
Start date
August 1, 2020
Completion date
August 31, 2021
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease stage3